<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Advanced glycation end products (AGE) accumulate in human tissue proteins during aging, particularly under <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> conditions </plain></SENT>
<SENT sid="1" pm="."><plain>AGEs induce <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:mp ids='MP_0001845'>inflammation</z:mp> via the receptor for AGEs (RAGE) and soluble RAGE (sRAGE) can neutralize the effects mediated by RAGE-ligand engagement </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We examined the association between N(Îµ)-(carboxymethyl)lysine (<z:mp ids='MP_0005481'>CML</z:mp>), a prominent AGE, and sRAGE and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk in a prospective case-cohort study nested within a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention trial among 29,133 Finnish male smokers </plain></SENT>
<SENT sid="3" pm="."><plain>Among study subjects who were alive without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> 5 years after baseline (1985-1988), we identified 483 incident <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases and randomly sampled 485 subcohort participants as the comparison group with the follow-up to April 2006 </plain></SENT>
<SENT sid="4" pm="."><plain>Baseline serum levels of <z:mp ids='MP_0005481'>CML</z:mp>-AGE, sRAGE, <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin were determined </plain></SENT>
<SENT sid="5" pm="."><plain>Weighted Cox proportional hazard regression models were used to calculate relative risks (RR) and 95% CI </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Comparing highest with lowest quintile of sRAGE, the RR for incident <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was 0.65 (95% CI, 0.39-1.07; P(trend) = 0.03), adjusting for age, years of smoking, body mass index, and <z:mp ids='MP_0005481'>CML</z:mp>-AGE </plain></SENT>
<SENT sid="7" pm="."><plain>Further adjustment for serum <z:chebi fb="105" ids="17234">glucose</z:chebi> strengthened the association (RR = 0.52; 95% CI, 0.30-0.89; P(trend) = 0.009) </plain></SENT>
<SENT sid="8" pm="."><plain>Highest quintile of <z:mp ids='MP_0005481'>CML</z:mp>-AGE was not associated with an increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (multivariate RR = 1.20; 95% CI, 0.64-2.26) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Higher prediagnostic levels of serum sRAGE were associated with lower risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in male smokers </plain></SENT>
<SENT sid="10" pm="."><plain>IMPACT: This is the first epidemiologic study to implicate the receptor for AGEs in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development </plain></SENT>
</text></document>